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DCs often require stimulation from CD4+ T cells to
propagate CD8+ T cell responses, but precisely
how T cell help optimizes the priming capacity of
DCs and why this appears to differ between varying
types of CD8+ T cell immunity remains unclear. We
show that CD8+ T cell priming upon HSV-1 skin infec-
tion depended on DCs receiving stimulation from
both IFN-a/b and CD4+ T cells to provide IL-15.
This was not an additive effect but resulted from
CD4+ T cells amplifying DC production of IL-15 in
response to IFN-a/b. We also observed that
increased innate stimulation reversed the helper
dependence of CD8+ T cell priming and that the
innate stimulus, rather than the CD4+ T cells them-
selves, determined how ‘‘help’’’ was integrated into
the priming response by DCs. These findings identify
T cell help as a flexible means to amplify varying sub-
optimal innate signals in DCs.INTRODUCTION
CD8+ T cells need to clonally expand and acquire effector func-
tion to eliminate virus-infected or tumor-transformed cells. This
differentiation of naive CD8+ T cells into effectors is referred to
as ‘‘priming’’ and the regulation of this process is a key function
of dendritic cells (DCs). Before DCs can propagate T cell priming,
they must themselves transition to a mature state that is charac-
terized by an increased capacity to present antigen and
enhanced expression of costimulatory molecules, such as
CD40. Signals inducing DC maturation are typically derived
from the stimulation of pattern recognition receptors and/or
exposure of DCs to inflammatory mediators (Vega-Ramos and
Villadangos, 2013). Interestingly, DCs often also need to inte-
grate a signal delivered from CD4+ T cells to gain full capacity
to prime naive CD8+ T cells (Bennett et al., 1998; Ridge et al.,586 Cell Reports 14, 586–597, January 26, 2016 ª2016 The Authors1998; Schoenberger et al., 1998). This process, which is also
known as ‘‘T cell help,’’ requires that antigen-specific CD4+
T cells stimulate CD40 molecules on their cognate antigen-pre-
senting DCs (Bevan, 2004; Wiesel and Oxenius, 2012).
In considering how T cell help improves DC-induced CD8+
T cell activation, it is important to appreciate that CD4+ T cells
are required for many, but not all, primary CD8+ T cell responses.
For example, CD8+ T cell responses to infections with lympho-
cytic choriomeningitis virus (LCMV) or influenza virus can be
primed in the absence of CD4+ T cells (Belz et al., 2002; Wang
et al., 2012). In contrast, CD8+ T cell responses to other stimuli,
such as infections with herpes simplex virus (HSV) (Rajasagi
et al., 2009; Smith et al., 2004) or vaccinia virus (Wiesel et al.,
2011) and cell-associated antigen (Behrens et al., 2004; Bennett
et al., 1998) require the presence of CD4+ T cells. These dispa-
rate helper requirements of CD8+ T cell priming are related to
the strength of the inflammatory response accompanying the
acquisition of antigen (Bevan, 2004). In particular, the magnitude
of the interferon-a/b (IFN-a/b) response associated with the
priming process has been reported to be a determining factor,
as helper-dependent CD8+ T cell responses can be rendered
helper independent by increasing IFN-a/b (Le Bon et al., 2003;
Wiesel et al., 2011). Conversely, helper-independent LCMV-spe-
cific CD8+ T cell responses become helper dependent upon
abrogation of MDA5-induced IFN-a/b secretion (Wang et al.,
2012). This inverse correlation between the strength of the in-
flammatory response and the helper dependence of the ensuing
CD8+ T cell response has led to the view that T cell help substi-
tutes (Bevan, 2004; Wiesel and Oxenius, 2012) for the cues that
DCs receive from innate stimuli in helper-independent situations.
However, experimental validations of such a substitute role are
missing and there is no coherent model that can explain why
some cytotoxic T lymphocyte (CTL) responses are helper depen-
dent while others are less so.
One idea of how T cell help could substitute for innate signals
suggests that CD4+ T cells regulate DC maturation when inflam-
matory mediators are insufficient to achieve this, proposing that
CD4+ T cells directly induce DC maturation via CD40 stimulation
(Bevan, 2004; Cella et al., 1996). Another model envisages that
T cell help regulates the provision of cytokines that DCs need to
deliver to CD8+ T cells for their full effector differentiation (Wiesel
et al., 2011). Notably, at least three different cytokines have been
implicated here. Using a model of helper-dependent CD8+ T cell-
mediatedallograft rejection, itwas reported thatCD4+Tcellswere
required to induce interleukin-12 (IL-12) secretionbyDCs (Filaten-
kov et al., 2005). In the context of vaccinia virus infections, T cell
help was suggested to regulate the provision of IFN-a/b from
DCs to vaccinia virus-specific CD8+ T cells (Wiesel et al., 2011),
whereas CD4+ T cells are believed to be required for IL-15 provi-
sionbyDCsduringhelper-dependent adenoviral vaccine-specific
CD8+Tcell responses (Ohet al., 2008).While thesestudiesgener-
ally support the idea that T cell help operates at the level of cyto-
kineprovisionbyDCs, they raise the intriguingquestionof how the
one signal (i.e., T cell help) can lead to such differing cytokine
requirements of the resulting CD8+ T cell response.
Given the above, we set out to systematically investigate how
T cell help regulates CD8+ T cell priming. Contrasting with the
current idea that T cell help substitutes for innate signals (Bevan,
2004; Wiesel and Oxenius, 2012), our findings are consistent
with a view of T cell help in which CD4+ T cells amplify innate sig-
nals that alone are insufficient to convert poorly immunogenic
DCs into those capable of effective priming. This is an important
distinction to the current model (Bevan, 2004; Wiesel and Oxe-
nius, 2012), as it entails that the innate signals associated with
a particular antigen determine the cytokine(s) that ultimately
mediate CD8+ T cell immunity and that T cell help simply serves
to amplify this response. Importantly, viewing T cell help as a
means to amplify innate signals explains why the ‘‘help’’ pro-
vided by CD4+ T cells can appear to be mediated via differing
cytokine responses, yet be delivered by the same mechanism,
i.e., CD40 stimulation.
RESULTS
CD8+ T Cell Response to HSV-1 Skin Infection Requires
T Cell Help
To dissect how T cell help improves the capacity of DCs to prime
antigen-specific CD8+ T cell responses in vivo, we employed a
model of peripheral HSV-1 infection (Bedoui et al., 2009; Davey
et al., 2010; van Lint et al., 2004). We first validated that the CD8+
T cell response to epicutaneous HSV-1 infection was helper
dependent as implied by our earlier work using different routes
of virus inoculation (Smith et al., 2004). For this, we infected
two different cohorts of CD4+ T cell-deficient mice with HSV-1
on the skin and assessed CD8+ T cell priming 7 days later in
the spleen, a time point that represents the peak of the priming
response (Coles et al., 2002; Davey et al., 2010). Both anti-
CD4 antibody-treated and MHC-II-deficient mice (H2-ab1/)
mounted impaired CD8+ T cell responses following HSV-1 skin
infection as assessed by expansion of CD8+ T cells specific for
the immunodominant epitope gB498–505 derived from HSV-1
glycoprotein B (Figure 1A). Together with the demonstration
that mice deficient in CD40L (CD40lg/) or CD40 (CD40/)
had similarly impaired primary HSV-specific CD8+ T cell re-
sponses (Figure 1B), these findings demonstrated that the
CD8+ T cell response to skin HSV-1 infection required CD4+
T cells and CD40L-CD40 interactions.CT Cell Help Is Not Required for DC Maturation following
HSV-1 Skin Infection
We considered the proposal that CD4+ T cells induce DC matu-
ration in helper-dependent scenarios (Bevan, 2004). To first
determine how accurately in vivo DC maturation could be
measured in our model, we isolated DCs from the brachial lymph
node that drains the site of HSV-1 skin infection 2 days later and
analyzed the DC compartment for surface markers classically
associated with DC maturation, including MHC-II and CD40
(Reis e Sousa, 2006). We focused on lymph node resident
CD8+ DCs (Figure 1C), as our previous studies have revealed
this subset of DCs to initiate CD8+ T cell priming in response to
HSV-1 skin infection (Allan et al., 2003; Bedoui et al., 2009).
CD8+ DCs from HSV-1 infected mice had increased surface
expression of MHC-II and CD40 relative to CD8+ DCs from unin-
fected mice (Figures 1D and 1E). This increase in MHC-II and
CD40 expression was not due to contaminating migratory DCs
in the CD8+ DC gate, as migratory DCs do not express CD8
(Bedoui et al., 2009). To validate that these phenotypic changes
represented biologically relevant DCmaturation that enabled the
priming of CD8+ T cells, we isolated MHC-IIhigh and MHC-IIlow
CD8+ DCs (Figure 1F) from the brachial lymph node of mice in-
fected 2 days earlier on the skin with HSV-1. These DCs were
co-incubated with 50,000 naive, Carboxyfluorescein succini-
midyl ester (CFSE)-labeled transgenic CD8+ gBT-I cells specific
for a H-2Kb-restricted epitope from glycoprotein B. Strikingly,
onlyMHC-IIhighCD8+DCs inducedgBT-I proliferation (Figure 1F),
confirming that the activated in vivoMHC-IIhigh phenotype corre-
lated with the capacity of CD8+ DCs to effectively stimulate naive
HSV-specific CD8+ T cells. Having confirmed MHC-II upregula-
tion as a surrogate marker for in vivo DC activation, we tested
the suggestion that CD4+ T cells contributed to DC activation
(Bevan, 2004). However, when comparing the ability of CD8+
DCs to increase MHC-II and CD40 expression in response to
HSV-1 skin infection, it was evident that DC activation occurred
regardless of the presence of CD4+ T cells (Figures 1G and 1H).
These findings indicated that the contribution of CD4+ T cells to
HSV-specific CD8+ T cell priming was not linked to the upregu-
lation of MHC-II and/or CD40 expression by CD8+ DCs.
IFN-a/b and IL-15 Are Crucial for Effective HSV-Specific
CD8+ T Cell Priming
Given that T cell help was not required for the increased expres-
sion of MHC-II and CD40 by CD8+ DCs associated with HSV-1
skin infection, we next considered the possibility that T cell
help could enhance the capacity of DCs to deliver cytokines to
the CD8+ T cells. We focused on IL-12, IFN-a/b, and IL-15, as
these have been suggested to play a role in other helper-depen-
dent types of CD8+ T cell responses (Filatenkov et al., 2005; Oh
et al., 2008; Wang et al., 2012; Wiesel et al., 2011). We infected
the relevant cytokine/cytokine receptor-deficient mice with
HSV-1 on the skin and determined the magnitude of the HSV-
specific CD8+ T cell response 7 days later. While we observed
no difference in HSV-specific CD8+ T cell priming in Il12b/
mice (Figure S1), we noted that the priming of endogenous
HSV-specific CD8+ T cells, as measured by H2-Kb-restricted
gB498–505 tetramers and intracellular cytokine staining for IFN-g
was impaired in mice lacking the IFN-a/b receptor (IFNaR2)ell Reports 14, 586–597, January 26, 2016 ª2016 The Authors 587
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Figure 1. CD4+ T Cells Are Required for HSV-Specific CD8+ T Cell Priming, but Not for CD8+ DC Activation
(A and B) Representative plots and absolute number of gB498–505-specifc CD8
+ T cells in the spleen of CD4+ T cell-deficient mice and wild-type B6 mice (WT)
(A) and Cd40lg/, Cd40/, and WT mice (B) infected with HSV-1 on flank skin 7 days earlier.
(C–E) Gating strategy (C) and CD40 (D) and MHC-II (E) surface expression on CD8+ DCs enriched from the brachial lymph node of mice infected on flank skin
2 days earlier with HSV-1 compared to CD8+ DCs from skin-draining lymph nodes of uninfected naive controls.
(F) Sort profiles of MHC-IIhigh CD8+ DCs (black squares) and MHC-IIlow CD8+ DCs (gray squares) from the brachial lymph nodes of mice infected on the skin with
HSV-1 2 days earlier. Absolute numbers of proliferated, CFSE-labeled gBT-I upon co-incubation with serial dilutions of CD8+ DCs for 60 hr are shown.
(G and H) Percent of MHC-IIhigh CD8+ DCs (G) and mean fluorescence intensity of CD40 expression on CD8+ DCs (H) from CD4-depleted and WT mice infected
2 days earlier with HSV-1 on flank skin.
All data are pooled results from at least two independent experiments (n = 5 per experiment) and are expressed as mean + SEM. Asterisks indicate statistically
significant differences versus controls as assessed by one-way ANOVA (A and B); *p < 0.05; **p < 0.001; ***p < 0.0001.
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AC D
B Figure 2. IFN-a/b and IL-15 Are Required for
HSV-Specific CD8+ T Cell Priming
(A–D) Representative plots and absolute number of
gB498–505-specifc CD8
+ T cells (A and C) and fre-
quency of IFN-g producing CD8+ T cells in the
spleen of Ifnar2/, Il15/, and WT mice infected
with HSV-1 on flank skin 6 or 7 days earlier (B and
D). Data are pooled from at least three independent
experiments (n = 5 per experiment) and expressed
as mean + SEM. Asterisks indicate statistically
significant differences versus controls as assessed
by Student’s t test; **p < 0.001; ***p < 0.0001.(Figures 2A and 2B) or IL-15 (Figures 2C and 2D). Figures S2A
and S2B show background staining with H2-Kb-restricted
gB498–505 tetramers and intracellular staining for IFN-g in
mock-infected mice. These findings demonstrated that HSV-
specific CD8+ T cell priming depended on both IFN-a/b and
IL-15, but not IL-12.
DC-Derived IL-15 Is Required for In Vivo Priming of HSV-
Specific CD8+ T Cells
If IFN-a/b and IL-15 acted as relevant signals in the direct interac-
tion between DCs and HSV-specific CD8+ T cells, then DCs
should be the relevant source of these cytokines and the CD8+
T cells should respond directly to them. We first tested whether
DCs were required to provide the IL-15. To this end, we reconsti-
tuted irradiated mice with a 1:1 mix of bone marrow from Il15/
mice andCD11c-DTR transgenic mice. The latter mice express a
highly sensitive diphtheria toxin receptor (DTR) that is primarily
expressed by DCs (Jung et al., 2002). After about 8 weeks of
reconstitution, these chimeras contained IL-15-competent DCs
from the CD11c-DTR bone marrow and IL-15-deficient DCs
derived from the Il15/ bone marrow. Diphtheria toxin (DTx)
treatment of these chimeras selectively eliminated IL-15-compe-
tent DCs, but not IL-15-deficient DCs, resulting in mice where
IL-15 was selectively missing from DCs. Notably, DTx-treated
chimeras infected with HSV-1 on the skin were impaired in
CD8+ T cell expansion (Figure 3A). The data are expressed as
relative change to control chimeras, because the magnitude of
the T cell responses in chimeras varied between experiments.
This impairment in CD8+ T cell priming was not due to an overall
reduction in DCs, as control chimeras in which wild-type DCs re-
mained after DTx treatment mounted CD8+ T cell responses that
were indistinguishable fromuntreated controls (Figure S3). These
finding indicated that DCs were the relevant source of IL-15
required for efficient in vivo HSV-specific CD8+ T cell priming.Cell Reports 14, 586–597DCs, but Not HSV-Specific CD8+ T
Cells, Require IFN-a/b Stimulation
We next addressed whether IFN-a/b also
acted as a crucial signal in the direct inter-
action between DCs and the CD8+ T cells.
Considering the ubiquitous expression of
IFNaR2, we first determined whether im-
mune cells were generally required to ex-
press IFNaR2 for optimal HSV-specific
CD8+ T cell priming through the use ofbone marrow chimeras. We observed that virus-specific CD8+
T cell priming in chimeras infected with HSV-1 on the skin was
only impaired if IFNaR2 was absent from the radiosensitive
bone-marrow-derived compartment (Figure 3B), indicating that
immune cells needed to express IFNaR2. To interrogate whether
the CD8+ T cells required IFNaR for optimal priming, we crossed
the gBT-I line onto the Ifnar2/ background and transferred
wild-type gBT-I and Ifnar2/ gBT-I into B6 mice 1 day before
infection with HSV-1 on the skin. Interestingly, gBT-I cells
expanded in response to the infection regardless of whether
they expressed IFNaR2 or not (Figure 3C), indicating that the
CD8+ T cells did not require direct stimulation by IFN-a/b. We
reasoned that DCs might instead be targeted by IFN-a/b and
tested this in mixed bone marrow chimeras reconstituted with
a 1:1 mix of bone marrow from Ifnar2/ mice and CD11c-DTR
transgenic mice. In support of this, DTx-treated chimeras in-
fected with HSV-1 on the skin were impaired in HSV-specific
CD8+ T cell expansion (Figure 3D), indicating that IFNaR2
expression by CD11chigh cells was required for efficient CD8+
T cell priming. A picture thus emerged in which the helper-
dependent priming of HSV-specific CD8+ T cells required both
IFN-a/b and IL-15, yet only IL-15 had to be provided from DCs
to the CD8+ T cells, while IFN-a/bwas required further upstream
(Figure 3E).
Enhanced IL-15 Production by Lymph-Node-Resident
CD8+ DCs after HSV-1 Skin Infection
To better understand this functional relationship between IL-15
and IFN-a/b, we examined IL-15 expression in CD8+ DCs, which
as mentioned above are key to the initiation of HSV-specific
CD8+ T cell priming (Bedoui et al., 2009). Interestingly, CD8+
DCs sorted from the brachial lymph node of mice infected on
the skin with HSV-1 2 days earlier increased the relative expres-
sion of Il15 when compared to those obtained from uninfected, January 26, 2016 ª2016 The Authors 589
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B C Figure 3. DCs Require Stimulation from
IFN-a/b and Provide IL-15 to HSV-Specific
CD8+ T Cells
(A) Relative proportion of gB498-505-specifc CD8
+
T cells in the spleen of chimeric mice containing a
1:1 mix of CD11c DTR and Il15/ bone marrow,
treatedwith DTx or PBS and infectedwith HSV-1 on
flank skin 7 days earlier.
(B) Relative proportion of gB498-505-specifc CD8
+
T cells in the spleen of WT or Ifnar2/ mice re-
constituted with Ifnar2/ or WT bone marrow
7 days after HSV-1 skin infection.
(C) Absolute number of WT and IFNaR2-deficient
gBT-I cells in the spleen on day 7 after infection of
B6 mice transferred with 2.5 3 104 naive WT or
IFNaR2-deficient gBT-I 1 day prior to infection with
HSV-1 on flank skin.
(D) Relative proportion of gB498–505-specifc CD8
+
T cells in the spleen of chimeric mice containing a
1:1 mix of CD11c DTR and Ifnar2/ bone marrow,
treated with DTx or PBS, and infected with HSV-1
on flank skin 7 days earlier.
(E) Helper-dependent priming of HSV-specific
CD8+ T cells required both IFN-a/b and IL-15,
yet only IL-15 had to be provided from DCs to the
CD8+ T cells, while IFN-a/b was required upstream
of this.
Data are pooled from at least two independent
experiments (n R 5 per experiment) and are ex-
pressed as mean + SEM. In the case of chimeras, data are expressed as percent change of control chimeras (CD45.1 > WT). Asterisks indicate statistically
significant differences versus controls as assessed by Student’s t test (A and D) and one-way ANOVA (B); **p < 0.001; ***p < 0.0001.mice (Figure 4A). To dissect whether this increase in IL-15 tran-
scription was uniform among the CD8+ DCs or specific to only
some, we examined surface expression of the a chain of the
IL-15 receptor, which is required for trans-presentation of IL-15
(Stonier and Schluns, 2010). Consistent with the transcription
data, we detected an increase in IL-15Ra surface protein expres-
sion on MHC-IIhi CD8+ DCs isolated from mice infected 2 days
earlier on the skin with HSV-1 (Figure 4B). Intriguingly, this in-
crease was restricted to CD8+ DCs that had upregulated
MHC-II expression (Figure 4C), highlighting that the induction
of IL-15 was specific to only some of the CD8+ DCs in that lymph
node. These findings indicated that lymph-node-resident CD8+
DCs increased IL-15/IL-15Ra expression in response to HSV-1
skin infection and that this increase was a distinct function of
CD8+ DCs that have acquired an activated phenotype. That
these helper-dependent changes in IL-15 production by CD8+
DCs occurred within 48 hr after HSV-1 skin infection also aligns
with the expected kinetics of T cell help, which is delivered within
the first 24–72 hr after antigen encounter (Mempel et al., 2004;
Shedlock and Shen, 2003; Smith et al., 2004).
T Cell Help and IFN-a/b Cooperate to Allow CD8+ DCs to
Provide IL-15
Equippedwith a better understanding of IL-15 regulation in CD8+
DCs following HSV-1 skin infection, we sought to resolve how
these processes were linked to the IFN-a/b-dependent nature
of the HSV-specific CD8+ T cell response and its requirement
for T cell help. With DCs requiring stimulation through IFN-a/b
(Figure 3D) and previous demonstrations showing that IFN-a/b
can induce IL-15 (Mattei et al., 2001), we questioned whether590 Cell Reports 14, 586–597, January 26, 2016 ª2016 The AuthorsIFNaR stimulation was required for the provision of IL-15 by
CD8+ DCs. Indeed, when we sorted CD8+ DCs from HSV-1-in-
fected Ifnar2/ mice, we noted that the increase in IL-15/IL-
15Ra expression was no longer evident (Figures 4A–4C). To
also resolve how these processes were linked to the helper-
dependent nature of the HSV-specific CD8+ T cell response,
we assessed whether the increase in IL-15/IL-15Ra expression
required CD4+ T cells. Interestingly, the increase in IL-15/IL-
15Ra expression by CD8+ DCs from HSV-1 infected mice was
also abrogated when infected mice were depleted of CD4+
T cells (Figures 4A–4C). These results indicated that the in vivo
provision of IL-15 by CD8+ DCs that is required for effective
CD8+ T cell priming depended on the DCs receiving both T cell
help and stimulation by IFN-a/b (Figure 4D). These findings
also established that neither T cell help nor IFN-a/b stimulation
alone were sufficient to increase IL-15 expression by CD8+
DCs in the context of HSV-1 skin infection.
CD40 Stimulation Amplifies IFN-a-Induced IL-15
Production
The above findings indicate an intriguing synergy in the regula-
tion of IL-15 between T cell help and IFN-a/b signals. To better
understand how these signals cooperated in allowing DCs to
provide IL-15, we employed an in vitro system in which equiva-
lents of CD8+ DCs (eCD8+ DCs), the DC subset responsible for
in vivo priming of HSV-specific CD8+ T cells (Bedoui et al.,
2009), can be grown from bone marrow cells by exposure to
FMS-like tyrosine kinase 3 ligand (flt3L) (Naik et al., 2005). We
sorted eCD8+ DCs on the basis of SIRPalow CD24hi expression
on day 8 from these cultures and stimulated them in vitro with
AC D
B Figure 4. T Cell Help and IFN-a/bCooperate
to Allow CD8+ DCs to Provide IL-15
(A) Relative expression (RE) of Il15 by CD8+ DCs
sorted from lymph nodes of uninfected controls or
Ifnar2/, anti-CD4 mAb-treated, and WT mice
infected 2 days earlier on flank skin with HSV-1.
(B and C) Frequency (B) and representative plots
(C) of IL-15Ra surface protein expression by
MHC-IIhi CD8+ DCs sorted from lymph nodes of
uninfected controls or Ifnar2/, anti-CD4 mAb-
treated, and WT mice infected 2 days earlier on
flank skin with HSV-1. Contour plots in (C) are
concatenated from four individual experiments.
(D) In vivo provision of IL-15 by CD8+ DCs required
for effective CD8+ T cell priming depended on the
DCs receiving both T cell help and stimulation by
IFN-a/b.
Data are pooled from at least three independent
experiments (n = 2–5 per experiment) and ex-
pressed as mean + SEM. Real-time PCR data are
expressed relative to gapdh expression. Asterisks
indicate statistically significant differences versus
controls as assessed by one-way ANOVA (A and
B); ***p < 0.0001.recombinant murine IFN-a A in the presence or absence of a
stimulating anti-CD40monoclonal antibody (FGK45) that mimics
T cell help (Bennett et al., 1998; Feau et al., 2011; Schoenberger
et al., 1998). When we assessed relative expression of Il15 by
eCD8+ DCs stimulated for 4 hr with escalating doses of IFN-a
A using real-time PCR, we observed that IFN-a A in the doses
tested hardly induced any IL-15 expression (Figure 5A). Intrigu-
ingly, when IFN-a A was administered together with the T cell
help mimicking anti-CD40 antibody, 1,000 U/ml IFN-a A induced
substantial IL-15 expression in the DC (Figure 5A). Notably, we
also observed a similar pattern of CD40-induced IL-15 amplifica-
tion when we stimulated freshly isolated CD8+ DCs with IFN-a A
ex vivo (Figure 5B). Importantly, this synergy was not due to an
additive effect between the two stimuli, as the anti-CD40 mAb
alone did not induce IL-15 in the DCs, evenwhen tested at higher
doses than those used in combination with IFN-a A (data not
shown). This synergistic activity was also not a consequence
of CD40-dependent IFN-a/b secretion from DCs that could
potentially act in an autocrine fashion to augment the original
signal, as the anti-CD40 mAb failed to elicit any IFN-a/b when
applied alone and also did not amplify CpG-induced IFN-a/b
secretion (data not shown). These findings demonstrated that
CD40 stimulation amplified the capacity of CD8+ DCs to provide
IL-15 in response to suboptimal IFN-a/b stimulation.Cell Reports 14, 586–597Increasing the Strength of Innate
Stimulation Reverses the Helper
Dependence of CD8+ T Cell Priming
When considered in the context of the
well-established observation that T cell
help for CD8+ T cell priming is indispens-
able when inflammatory signals associ-
ated with the response are weak (Bevan,
2004; Wiesel and Oxenius, 2012), the
above findings imply that T cell helpserves to amplify IFN-a/b signals that alone are insufficient to
elicit the required IL-15 response by DCs. To further investigate
this possibility and to validate findings from our HSV-1 skin
infections in another model of helper-dependent CD8+ T cell
priming, we exposed mice to cell-associated ovalbumin (OVA)
and determined how the strength of an accompanying IFN-
a/b signal would affect the helper-requirement of the ensuing
endogenous OVA-specific CD8+ T cell response. We chose
Poly(I:C) as the inflammatory stimulus due to its potent ability
to elicit IFN-a/b secretion in vivo and its common use as an
adjuvant to stimulate DCs (Soares et al., 2007). Consistent
with our earlier work (Bennett et al., 1998), cell-associated
OVA induced a CD8+ T cell response in the spleen 7 days after
antigen challenge that had a distinct helper dependence (shown
as relative change in Figure 5C and as absolute numbers in
Figure S4). Interestingly, this helper dependence became less
stringent with increasing amounts of Poly(I:C) delivered at the
time of antigen provision (Figure 5C). Critically, although the
helper dependence of the response could be reversed by
increasing the strength of the Poly(I:C) stimulus, the OVA-spe-
cific CD8+ T cell response depended on IL-15 regardless of
whether it required T cell help or not (Figure 5D). These obser-
vations extended the importance of T cell help amplified IL-15
to another type of helper-dependent CD8+ T cell priming and, January 26, 2016 ª2016 The Authors 591
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b-Induced IL-15
(A) Relative expression (RE) of Il15 by eCD8+ DCs
sorted from flt3L-stimulated B6 bonemarrow cultures
stimulated with escalating concentrations of IFN-a A
in the presence (open squares) or absence (closed
squares) of anti-CD40 mAb.
(B) RE of Il15 by freshly isolated splenic XCR1+ CD8+
DCs stimulated with IFN-a A in the presence (open
squares) or absence (closed squares) of anti-CD40
mAb.
(C) Relative expansion of OVA-specific CD8+ T cells in
the spleen 7 days after injection of cell-associated
OVA in the presence of various doses of Poly(I:C) into
CD4-depleted and PBS-treated WT mice.
(D) Relative expansion of OVA-specific CD8+ T cells in
the spleen 7 days after injection of cell-associated
OVA in the presence of 5 mg and 0.05 mg Poly(I:C) into
Il15/ and WT mice.
(E) CD4+ T cells amplify the IFN-a/b-induced provision
of IL-15 by CD8+ DCs to CD8+ T cells responding to
cognate antigen.
Data are pooled from two independent experiments
(n = 2–5 per experiment) and are expressed asmean +
SEM. Relative expansion is expressed as percent
change of WT control. Real-time PCR data are
expressed relative to gapdh expression. Asterisks
indicate statistically significant differences versus
controls as assessed by Student’s t test (A and C) or
one-way ANOVA (B); *p < 0.05; **p < 0.001.indicated that elicitation of the IL-15 pathway only depended
heavily upon T cell help when the innate signal inducing this
pathway was limiting.
CD40 Stimulation Amplifies IFN-a4-Induced Chemokine
and IL-6 Production
Rather than CD4+ T cells delivering a distinct signal to DCs that
substitutes for absent or insufficient innate stimulation (Bevan,
2004; Wiesel and Oxenius, 2012), our observations identify
T cell help as a means to amplify the efficiency with which IFN-
a/b elicit IL-15 in DCs (Figure 5E). These observations not only
suggest that the relevance of T cell help should be seen as a
function of the strength of the IFN-a/b signal but also raise the
intriguing question of whether CD4+ T cells can amplify other
molecules induced through IFN-a/b. To address this, we
analyzed the supernatants from IFN-a A-stimulated eCD8+592 Cell Reports 14, 586–597, January 26, 2016 ª2016 The AuthorsDCs for molecules that have been associ-
ated with T cell help for CD8+ T cell priming.
While IL-12p40 (Filatenkov et al., 2005)
could not be detected in response to IFN-a
A (data not shown), this stimulus evoked a
dose-dependent increase in CCL3 and
CCL4, chemokines that both have been pre-
viously shown to play an important role in
the spatiotemporal regulation of T cell help
(Castellino et al., 2006) (Figure 6A). Stimu-
lating the DCs with IFN-a A in the presence
of anti-CD40 mAb further enhanced CCL4
secretion (Figure 6A). Interestingly, whenwe measured two other molecules that have been discussed in
the context of T cell help, namely IL-6 (Castellino and Germain,
2007) and CCL5 (Crawford et al., 2011), we noticed a pattern,
in which IFN-a A alone was barely capable of inducing IL-6
and CCL5 at the concentrations tested (Figure 6A). However,
when assisted by the anti-CD40 mAb, these doses of IFN-a A
now induced IL-6 and CCL5 secretion from the DCs (Figure 6A).
Comparable to the effects on IL-15 (Figure 5A), the amplifying
effect of CD40 was not simply an additive effect between
IFN-a A and CD40 stimulation, as the anti-CD40 mAb alone did
not induce any of these factors. These findings demonstrated
that mimicking T cell help in vitro increased the sensitivity
and capacity of eCD8+ DCs to produce a wider range of IFN-
stimulated downstream mediators, indicating that T-cell-help-
mediated amplification of innate signals was not unique to the
IFN-a/b-IL-15 axis.
AB C
Figure 6. The Innate Stimulus Determines
How T Cell Help for CD8+ T Cell Priming Is
Mediated
(A) CCL3, CCL4, CCL5, and IL-6 protein levels in
the supernatants of eCD8+ DCs sorted from flt3L-
stimulated bone marrow cultures stimulated with
escalating concentrations of IFN-a A in the pres-
ence (open squares) or absence (closed squares)
of anti-CD40 mAb for 4 hr.
(B) Relative expansion of OVA-specific CD8+
T cells in the spleen 7 days after injection of cell-
associated OVA in the presence of 1 mg LPS into
Il15/, Il12b/, CD4-depleted, and WT mice.
(C) Relative expansion of OVA-specific CD8+
T cells in the spleen 7 days after injection of cell-
associated OVA in the presence of 0.05 mg
Poly(I:C) into Il15/, Il12b/, CD4-depleted, and
WT mice.
Data are pooled from at least two independent
experiments (n = 5 per experiment) and are ex-
pressed as mean + SEM. Relative expansion is
expressed as percent change of WT control. As-
terisks indicate statistically significant differences
versus controls as assessed by Student’s t test (A)
and one-way ANOVA (B and C); *p < 0.05; **p <
0.001; ***p < 0.0001.The Innate Stimulus Determines How TCell Help Assists
in CD8+ T Cell Priming
Finally, we considered how these insights into how T cell help
works could help explain the puzzling observations that T cell
help can be mediated through alternative cytokines in different
models of CD8+ T cell priming (Filatenkov et al., 2005; Oh
et al., 2008;Wiesel et al., 2010). As the nature of the innate stimuli
associated with the respective antigenic challenge likely differs
substantially between the different models of CD8+ T cell prim-
ing, and our findings above showed that T cell help was not
uniquely linked to a single innate circuit (i.e., IFN-a/b-IL-15
axis), we reasoned that CD4+ T-cell-dependent amplification
might also apply to innate pathways elicited through other
danger signals. This was a particularly compelling notion, as it
implied that the type of innate stimulus determined how T cell
help was mediated, rather than the CD4+ T cells themselves se-
lecting the downstream signals that aid CD8+ T cell priming. To
test this hypothesis in vivo, we exposed mice again to cell-asso-
ciated OVA, but this time also included a group in which we
administered LPS instead of Poly(I:C), creating a situation in
which CD8+ T cell priming in response to the same source of an-
tigen was associated with stimulation of different innate path-
ways. In agreement with our earlier work (Bennett et al., 1998),Cell Reports 14, 586–597LPS-adjuvanted cell-associated OVA
induced a helper-dependent antigen-
specific CD8+ T cell response (Figure 6B).
Strikingly, although themicewereexposed
to the same source of antigen, stimulation
of different innate pathways at the time of
priming changed the cytokine require-
ments of the ensuing helper-dependent
OVA-specific CD8+ T cell response. Here,the Poly(I:C)-adjuvanted, helper-dependent OVA-specific CD8+
T cell response required IL-15, but not IL-12p40 (Figure 6C),
whereas the presence of LPS changed this profile so that OVA-
specific CD8+ T cell priming no longer required IL-15, but was
now dependent on IL-12p40 (Figure 6B). These experiments
demonstrated that T cell help can be associated with different
cytokine responses in the one model system and highlighted
that the innate stimulus determined how CD4+ T cells aided in
CD8+ T cell priming.
DISCUSSION
This study has investigated howCD4+ T cells improve the capac-
ity of DCs to prime antigen-specific CD8+ T cell responses. Our
comprehensive in vivo analysis of mice infected with HSV-1 re-
vealed an intriguing scenario in which CD8+ DCs required stim-
ulation by both IFN-a/b and CD4+ T cells to produce the IL-15
that naive CD8+ T cells responding to cognate antigen required
for their effector differentiation (Figure 5E). In showing that the
provision of T cell help in the absence of innate signals failed
to elicit IL-15 by DCs and that the helper dependence of
OVA-specific CD8+ T cell priming, but not its requirement for
IL-15, could be reversed by increasing the strength of innate, January 26, 2016 ª2016 The Authors 593
stimulation, our data indicate that T cell help amplified the ca-
pacity of IFN-a/b to elicit IL-15 in DCs when the IFN-a/b signal
alone was ineffective to achieve this. Importantly, CD4+ T-cell-
mediated amplification of IFN-a/b signals was not exclusively
linked to the provision of IL-15, as CD40 stimulation also facili-
tated and enhanced the provision of other mediators that are
important for T cell help, namely CCL4, CCL5, and IL-6 (Castel-
lino and Germain, 2007; Castellino et al., 2006; Crawford et al.,
2011). Together with our observation that altering the innate
stimulus delivered alongside the same antigen changed the
cytokine requirement of the ensuing helper-dependent anti-
gen-specific CD8+ T cell response, these findings demonstrate
an inextricable link between T cell help and innate immune stim-
ulation of DCs. Taken together, this study supports a model of
T cell help, in which CD4+ T cells amplify the capacity of DCs
to respond to the innate signals generated by the particular envi-
ronment in which they have encountered antigen. This is an
important advance from current models (Bevan, 2004; Wiesel
and Oxenius, 2012), as it illustrates that the innate signals, and
not the CD4+ T cells themselves, determine the downstream
cytokines that ultimately ‘‘help’’ CD8+ T cells. Such an ‘‘amplifi-
cation model’’ of T cell help is consistent with the well-estab-
lished observation that priming of CD8+ T cell responses under
conditions of weak inflammation is particularly helper depen-
dent. However, rather than CD4+ T cells substituting for ineffec-
tive or absent inflammatory and/or microbial stimuli, our data
indicate that innate signals still play a crucial role in helper-
dependent responses. While these signals alone are likely sub-
optimal and therefore require CD4+ T-cell-mediated amplifica-
tion, they are nevertheless crucial as they dictate the resulting
cytokine responses that support CD8+ T cell priming. This view
on T cell help aligns with a previous report showing that CD40-
stimulated CD8+ DCs only secreted IL-12 in vivo when the DCs
were co-exposed to microbial products (Schulz et al., 2000).
Our findings also substantiate previous speculations that T cell
help might be linked to the modulation of danger signals (Castel-
lino and Germain, 2007; Macagno et al., 2007; Schulz et al.,
2000). Overall, the present study highlights that the amplification
of innate signals by CD4+ T cells represents an important func-
tional aspect of T cell help that likely co-exists with additional
DC-dependent or DC-independent mechanisms of T cell help.
In showing that the cytokine requirement of helper-dependent
CD8+ T cell priming can be changed by altering the inflammatory
stimulus provided at the time of antigen challenge, this study
provides an answer to the puzzling question of how T cell help
for different CD8+ T cell responses could be mediated through
alternative cytokines (Filatenkov et al., 2005; Oh et al., 2008;Wie-
sel et al., 2011). Considering that allograft responses (Filatenkov
et al., 2005) and adenoviral vector immunization (Oh et al., 2008)
will most likely be associated with different sets of danger sig-
nals, our data predict that CD4+ T cells simply amplified alterna-
tive innate circuits in DCs and therefore differed in the way they
aided in CD8+ T cell priming. In the case of the allograft response
(Filatenkov et al., 2005), CD4+ T cells likely facilitated the provi-
sion of IL-12 by DCs, whereas they appear to have promoted
DCs to deliver IL-15 following adenoviral vector vaccination
(Oh et al., 2008). Accordingly, this explains how T cell help can
appear to vary in nature, yet be mediated by the same mecha-594 Cell Reports 14, 586–597, January 26, 2016 ª2016 The Authorsnism. The importance of a flexible system that allows CD4+
T cells to amplify differing cytokine responses is further empha-
sized by our observations that CD8+ T cell priming required either
IL-12p40 or IL-15, but not both at the same time. When inter-
preted in the context of reports showing that primary CD8+
T cell responses against Listeria monocytogenes required
IL-12p40 (Oxenius et al., 1999), but not IL-15 (Sandau et al.,
2010), while CD8+ T cell priming upon HSV-1 infection, as shown
here, or in response to vesicular stomatitis virus infection de-
pended on IL-15 (Schluns et al., 2002), but not IL-12 (Keppler
et al., 2012; Sandau et al., 2010), it is possible that these distinct
cytokine requirements of primary CD8+ T cell responses could
be related to DCs encountering bacteria or viruses, respectively.
It is also conceivable that these differential priming requirements
could be associated with changes in the relative responsiveness
of the T cells to the cytokines induced by the specific innate stim-
ulus. Whatever the underlying reasons for this variability in the
priming requirements of CD8+ T cells, the fact that different
innate pathways can support CD8+ T cell priming (Ahonen
et al., 2004) further supports our proposal that T cell help pro-
vides a flexible means through which varying innate circuits
can be amplified.
By demonstrating that T cell help amplifies innate signals, our
work identifies an important mechanism through which CD4+
T cells endow DCs with optimal capacities to prime CD8+
T cells when danger signals alone are insufficient to achieve
this. This is highly relevant to CD8+ T cell priming in infections
where microbial immune evasion strategies (Bedoui et al.,
2010) or restriction of pathogen replication to peripheral tissues
(van Lint et al., 2004) limit the availability of danger signals at sites
of T cell priming. Similarly, T-cell-help-induced amplification of
innate pathways likely contributes to tumor-specific CD8+
T cell priming, which often is associated with limited exposure
to danger signals. However, as indiscriminate amplification of
innate circuits in DCs and the resulting facilitation of CD8+
T cell priming can also be dangerous, particularly when it occurs
in DCs presenting self or environmental antigens, a sufficiently
high activation threshold needs to be imposed on CD4+ T-cell-
induced amplification of innate signals. This is likely achieved
by restricting the provision of T cell help to cognate interactions
between the CD4+ T cell and the DC (Bennett et al., 1998; Smith
et al., 2004). Defining T cell help therefore as an antigen-specific
means through which innate stimulation of DCs can be regulated
could be interpreted as a checkpoint system, in which DCs
acquiring antigen in the context of limited danger signals
‘‘seek’’ validation from cognate CD4+ T cells. Only if the addi-
tional indirect information obtained through this validation step
is successfully integrated into the process (i.e., concurrent ac-
cess of the DC to MHC-II restricted epitopes; presence and
appropriate spatiotemporal activation of cognate CD4+ T cells)
will the innate stimuli be amplified to levels that support CD8+
T cell priming by the DC.
In summary, the present study has demonstrated an inextri-
cable association between innate signals and T cell help through
which antigen-specific control of innate circuits regulates how
DCs respond to danger signals and subsequently gain the capac-
ity to prime CD8+ T cell responses. These insights not only have
important implications for our conceptual view on T cell help but
also further highlight the proposal that DC maturation should not
be viewed as a binary ‘‘on-off’’ event (Reis e Sousa, 2006), but
rather as a process inwhich the integration ofmultiple signal qual-
ities (Macagnoetal., 2007)determines theoverall capacityof aDC
to evoke effector differentiation of T cells (Joffre et al., 2009).
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, H2-ab1/, Il15/, Il12b/, Ifnar2/, Cd40/, Cd40lg/,
CD45.1+ gBT-I, gBT-I on an Ifnar2/ background (Ifnar2/ gBT-I), and
CD11c DTR mice were bred and maintained at the Department of Microbi-
ology and Immunology at the University of Melbourne animal facility. The Uni-
versity of Melbourne Animal Ethics Committee approved all animal
experiments.
Viruses and Virus Infection
Wild-type HSV-1 KOS was grown using Vero cells (CSL). Mice were infected
epicutaneously with 106 plaque-forming units of HSV-1 as previously
described (van Lint et al., 2004). Some mice were treated on days 3 and
1 before infection or antigen challenge with 100 mg anti-CD4 mAb (GK1.5,
WEHI recombinant antibody facility, Melbourne) intraperitoneally.
Preparation of Cell-Associated OVA
For the preparation of cell-associated OVA, splenocytes from C57BL/6 mice
were isolated in RPMI 1640 medium supplemented with 10% fetal calf serum
(FCS), washed, and g irradiated (1,500 rads) as previously described (Bennett
et al., 1998). The cells were then washed once prior to incubation with
10 mg/ml OVA protein in Hank’s balanced salt solution (HBSS) for 10 min at
37C. After three subsequent washes the cells were filtered and 2 3 107 cells
were injected per mouse intravenously in 0.2 ml of HBSS. In some
experiments, cell-associated OVA was co-administered with Poly(I:C) (0.05 mg–
5mg/mouse; InvivoGen) orLPS (1mg/mouse;Difco,derived fromE.coli0111:B4).
CD8+ DCs Isolation
Single-cell suspensions from naive spleen or brachial lymph nodes of mice in-
fected with HSV-1 2 days earlier or from pooled inguinal, cervical, and brachial
LN of naive C57BL/6 mice were enriched for conventional DCs (excluding
plasmacytoid DCs) using antibodies against Gr-1 (RB6-8C5), CD3ε (KT3),
CD19 (ID6), Thy1 (T24), B220 (RA36B2), and erythrocytes (Ter-119) and mag-
netic bead depletion as previously described (Bedoui et al., 2009). Purity of the
enriched cell suspension usually yielded between 60%and 85%CD11c+ cells.
Cells were stained with antibodies against CD11c (N418), CD8 (53-6.7), XCR1
(ZET, Biolegend), CD3 (145-2C11, BD Biosciences), CD19 (1D3), NK1.1
(PK136), CD40 (MR1), IA/E (2G9), and IL-15Ra (FAB551F). CD8+ DCs were
either processed on an analytic flow cytometer (FACS Canto or LSR Fortessa
BD Biosciences) or flow cytometrically sorted (FACS Aria, BD Biosciences)
based on the following characteristics: CD11chi, MHC-IIhi/int, XCR1+, and
CD8+. Sorted CD8+ DCs from the spleen were used for real-time PCR (Fig-
ure 5B). CD8+ DCs sorted from brachial lymph nodes of HSV-1-infected
mice (Figure 1F) were co-cultured with CFSE-labeled gBT-1 cells for 60 hr. Pu-
rity of sorted CD8+ DCs routinely exceeded 94%.
Flow Cytometry Analysis of Endogenous, Virus-Specific CD8+ T
Cells
Anti-viral CD8+ T cells specific for gB498–505 from HSV-1 were measured in the
spleen or lymph nodes using H-2Kb-restricted gB498–505-specific tetramers.
After surface staining with anti-CD8 mAb (53.6-7), anti-CD44 mAb (IM7), and
tetramer staining, viable CD8+ CD44+ tetramer+ cells were determined by
flow cytometry. Intracellular gB498–505-induced IFN-g production was deter-
mined as previously described (Smith et al., 2004).
Preparation and Proliferation Analysis of Virus-Specific Transgenic
T Cells
gBT-I and Ifnar2/ gBT-I were purified as described (Bedoui et al., 2009). In
brief, T cells isolated from lymph nodes and spleens were enriched by incu-Cbation for 30 min with antibodies against Mac-1 (M1/70), F4/80 (F4/80),
erythrocytes (TER-119), Gr-1 (RB6-8C5), I-A/E (M5114), and CD4 (GK1.5)
for CD8+ T cell enrichment. Cells binding the antibodies were removed
with goat anti-rat IgG-coupled magnetic beads (QIAGEN). Purity of the
enrichment was routinely 90%–95% as determined by flow cytometry. En-
riched naive gBT-I were intravenously transferred into mice 1 day before
infection. In some experiments, enriched T cells were further processed for
labeling with 2.5 mM CFSE (Sigma) to be used in ex vivo antigen presentation
assays. For this, 5 3 104 CFSE-labeled gBT-I were co-cultured with graded
concentrations of purified CD8+ DCs from HSV-1 infected mice for 60 hr.
Proliferation was measured by CFSE dilution of CD8+ T cells using a flow
cytometer.
Bone Marrow Chimeras
Mixed chimeras were generated as previously described (Davey et al., 2010).
In brief, C57BL/6 or congenic CD45.1 mice were lethally irradiated with 2 3
550 cGy and reconstituted with a 1:1 mix of 2.5 3 106 T-cell-depleted bone
marrow cells from Ifnar2/ or Il15/ mice and transgenic CD11c DTR.
Chimeric mice were allowed to reconstitute for at least 8 weeks. Depletion
of CD11c+ cells was achieved by injecting mixed chimeras containing BM
from CD11c DTR twice with 100 ng of DTx on days3 and1 via the intraper-
itoneal route before analysis.
In Vitro Generation of eCD8+ DCs
For in vitro generation of murine bone-marrow-derived DCs, bone marrow
from B6 mice was cultured in the presence of flt3L as described previously
(Naik et al., 2005). Bone marrow cells were centrifuged once and resuspended
in 1ml of RBC lysis buffer (Sigma-Aldrich) for 15 s. Cells were cultured at 1.53
106/ml in complete Media supplemented with glutamax, FCS, antibiotics, and
100 ng/ml human FLt3L (BioXCell) for 8 days at 37C. Then cultures were
sorted on the basis of PDCA1, SIRPa, CD11c, CD11b, and CD24 in accor-
dance with previous work (Lauterbach et al., 2010). 5 3 105 CD11blo SIRPalo
CD24high DCs (eCD8+ DCs) were stimulated for 4 hr with IFN-a A (PBL) in the
presence or absence of anti-CD40 mAb.
Cytokine and Chemokine Determination
Supernatants were harvested from sorted flt3L DC cultures 4 hr post stimula-
tion and assessed for CCL3, CCL4, CCL5, IL-6, and IL-12/23p40 by BD cyto-
metric bead array kits according tomanufacturer’s instructions. Samples were
assessed using a LSR Fortessa with all concentrations determined relative to a
standard curve.
Real-Time PCR
For quantitative real-time PCR analysis, RNA was extracted using RNeasy Mi-
cro Kit (QIAGEN) and cDNA synthesized with SuperScript III Reverse Tran-
scriptase (Invitrogen) using oligo-dT primers (Promega). Real-time PCR was
performed with Fast SYBR green Master mix (Life Technologies) with primers
for IL-15 (50-TTACGCGCTGCAGGGACC-30 and 50-AGGGCCATGTGTCAA
GGT GG-30) and Gapdh (50-CCA GGT TGT CTC CTG CGA CTT-30 and 50-CCT
GTT GCT GTAG CCG TAT TCA-30). Il15 mRNA expression was normalized to
Rn18s (Figure 4A) or Gapdh (Figure 5) and relative expression (RE) was deter-
mined (RE = 2(DDCT)).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software.
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